UNICHEMLABPharmaceuticals
Unichem Laboratories Ltd — Profit & Loss Statement
₹293.45
-4.90%
Unichem Laboratories Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 1.11 Cr | 0.00 | -9.50 Cr | -1.34 Cr | — |
| Tax Rate For Calcs | 0.11 | 0.00 | 0.30 | 0.31 | — |
| Normalized EBITDA | 289.64 Cr | 109.86 Cr | -15.02 Cr | 122.57 Cr | — |
| Total Unusual Items | 10.21 Cr | -49.51 Cr | -31.65 Cr | -4.35 Cr | — |
| Total Unusual Items Excluding Goodwill | 10.21 Cr | -49.51 Cr | -31.65 Cr | -4.35 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 137.52 Cr | -93.76 Cr | -202.23 Cr | 33.06 Cr | — |
| Reconciled Depreciation | 124.56 Cr | 123.16 Cr | 113.44 Cr | 91.23 Cr | — |
| Reconciled Cost Of Revenue | 995.31 Cr | 864.13 Cr | 673.17 Cr | 518.59 Cr | — |
| EBITDA | 299.85 Cr | 60.35 Cr | -46.67 Cr | 118.22 Cr | — |
| EBIT | 175.29 Cr | -62.81 Cr | -160.11 Cr | 26.99 Cr | — |
| Net Interest Income | -18.18 Cr | -21.99 Cr | -16.80 Cr | 0.37 Cr | — |
| Interest Expense | 20.70 Cr | 22.15 Cr | 16.25 Cr | 5.02 Cr | — |
| Interest Income | 2.85 Cr | 0.67 Cr | 0.52 Cr | 6.48 Cr | — |
| Normalized Income | 128.42 Cr | -44.25 Cr | -180.07 Cr | 36.07 Cr | — |
| Net Income From Continuing And Discontinued Operation | 137.52 Cr | -93.76 Cr | -202.23 Cr | 33.06 Cr | — |
| Total Expenses | 1.92K Cr | 1.77K Cr | 1.46K Cr | 1.26K Cr | — |
| Rent Expense Supplemental | 1.76 Cr | 1.55 Cr | 0.86 Cr | 1.92 Cr | — |
| Diluted Average Shares | 7.06 Cr | 7.04 Cr | 7.04 Cr | 7.06 Cr | — |
| Basic Average Shares | 7.04 Cr | 7.04 Cr | 7.04 Cr | 7.04 Cr | — |
| Diluted EPS | 19.47 | -13.32 | -28.72 | 4.68 | — |
| Basic EPS | 19.53 | -13.32 | -28.72 | 4.70 | — |
| Diluted NI Availto Com Stockholders | 137.52 Cr | -93.76 Cr | -202.23 Cr | 33.06 Cr | — |
| Net Income Common Stockholders | 137.52 Cr | -93.76 Cr | -202.23 Cr | 33.06 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 137.52 Cr | -93.76 Cr | -202.23 Cr | 33.06 Cr | — |
| Net Income Including Noncontrolling Interests | 137.52 Cr | -93.76 Cr | -202.23 Cr | 33.06 Cr | — |
| Net Income Continuous Operations | 137.52 Cr | -93.76 Cr | -202.23 Cr | 33.06 Cr | — |
| Tax Provision | 17.07 Cr | 8.80 Cr | 25.86 Cr | -11.09 Cr | — |
| Pretax Income | 154.59 Cr | -84.96 Cr | -176.36 Cr | 21.97 Cr | — |
| Other Non Operating Income Expenses | 0.70 Cr | 0.42 Cr | 0.34 Cr | 0.51 Cr | — |
| Special Income Charges | 0.95 Cr | -55.98 Cr | -40.70 Cr | -7.47 Cr | — |
| Other Special Charges | -0.95 Cr | 55.98 Cr | 37.28 Cr | 0.23 Cr | — |
| Net Non Operating Interest Income Expense | -18.18 Cr | -21.99 Cr | -16.80 Cr | 0.37 Cr | — |
| Total Other Finance Cost | 0.33 Cr | 0.51 Cr | 1.06 Cr | 1.08 Cr | — |
| Interest Expense Non Operating | 20.70 Cr | 22.15 Cr | 16.25 Cr | 5.02 Cr | — |
| Interest Income Non Operating | 2.85 Cr | 0.67 Cr | 0.52 Cr | 6.48 Cr | — |
| Operating Income | 140.30 Cr | -36.28 Cr | -155.58 Cr | -10.90 Cr | — |
| Operating Expense | 928.87 Cr | 909.78 Cr | 784.83 Cr | 740.30 Cr | — |
| Other Operating Expenses | 174.62 Cr | 171.21 Cr | 164.96 Cr | 151.19 Cr | — |
| Depreciation And Amortization In Income Statement | 124.56 Cr | 123.16 Cr | 113.44 Cr | 91.17 Cr | — |
| Amortization | 11.23 Cr | 0.00 | 0.07 Cr | 0.12 Cr | — |
| Depreciation Income Statement | 113.33 Cr | 123.16 Cr | 113.37 Cr | 91.17 Cr | — |
| Research And Development | 18.51 Cr | 25.14 Cr | 26.39 Cr | 33.76 Cr | — |
| Selling General And Administration | 253.08 Cr | 232.46 Cr | 162.88 Cr | 153.16 Cr | — |
| Selling And Marketing Expense | 202.01 Cr | 183.92 Cr | 129.56 Cr | 120.68 Cr | — |
| General And Administrative Expense | 51.07 Cr | 48.54 Cr | 33.32 Cr | 32.48 Cr | — |
| Rent And Landing Fees | 1.76 Cr | 1.55 Cr | 0.86 Cr | 1.92 Cr | — |
| Gross Profit | 1.07K Cr | 873.50 Cr | 629.25 Cr | 729.39 Cr | — |
| Cost Of Revenue | 995.31 Cr | 864.13 Cr | 673.17 Cr | 518.59 Cr | — |
| Total Revenue | 2.06K Cr | 1.74K Cr | 1.30K Cr | 1.25K Cr | — |
| Operating Revenue | 2.06K Cr | 1.74K Cr | 1.30K Cr | 1.25K Cr | — |
| Write Off | — | 0.00 | 3.42 Cr | 7.24 Cr | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Unichem Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.